- Home
- LMND vs IRON Comparison
LMND vs IRON Comparison
Compare LMND & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMND
- IRON
- Stock Information
- Founded
- LMND 2015
- IRON 2017
- Country
- LMND United States
- IRON United States
- Employees
- LMND N/A
- IRON N/A
- Industry
- LMND Property-Casualty Insurers
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- LMND Finance
- IRON Health Care
- Exchange
- LMND Nasdaq
- IRON Nasdaq
- Market Cap
- LMND 2.8B
- IRON 1.8B
- IPO Year
- LMND 2020
- IRON N/A
- Fundamental
- Price
- LMND $43.76
- IRON $51.38
- Analyst Decision
- LMND Hold
- IRON Strong Buy
- Analyst Count
- LMND 10
- IRON 10
- Target Price
- LMND $33.70
- IRON $93.40
- AVG Volume (30 Days)
- LMND 3.1M
- IRON 411.3K
- Earning Date
- LMND 07-29-2025
- IRON 08-07-2025
- Dividend Yield
- LMND N/A
- IRON N/A
- EPS Growth
- LMND N/A
- IRON N/A
- EPS
- LMND N/A
- IRON N/A
- Revenue
- LMND $558,600,000.00
- IRON N/A
- Revenue This Year
- LMND $29.15
- IRON N/A
- Revenue Next Year
- LMND $31.39
- IRON N/A
- P/E Ratio
- LMND N/A
- IRON N/A
- Revenue Growth
- LMND 23.12
- IRON N/A
- 52 Week Low
- LMND $14.90
- IRON $30.82
- 52 Week High
- LMND $53.85
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- LMND 65.36
- IRON 56.63
- Support Level
- LMND $40.75
- IRON $52.52
- Resistance Level
- LMND $42.74
- IRON $55.52
- Average True Range (ATR)
- LMND 2.98
- IRON 2.39
- MACD
- LMND 0.06
- IRON 0.03
- Stochastic Oscillator
- LMND 94.12
- IRON 61.58
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.